Safety Alert

# Title Type of news Date Link of news
222 Safety Signal of Baricitinib and the Risk of Fracture Signal
221 Safety Signal of Exenatide and the Risk of Hepatocellular Carcinoma Signal
220 Safety Signals Identified by SFDA (July - September) 2025 Signal
219 Safety Signal of Cytarabine and the Risk of Palmar plantar erythrodysaesthesia syndrome Signal
218 Safety Signal of Adalimumab and the Risk of Osteonecrosis Signal
217 Safety Signal of Lenvatinib and the Risk of Tumour lysis syndrome Signal
216 Safety Signal of Onasemnogene abeparvovec and the Risk of Hypercalcaemia Signal
215 Safety Signal of Adalimumab and the Risk of Antiphospholipid syndrome Signal
214 Safety Signal of Atorvastatin and the Risk of Anxiety Signal
213 Safety Signal of Dasabuvir and the Risk of Increased appetite Signal
Displaying 1 - 10 of 224